Skip to content

Clinical trials

Completed Phase 1/2 Lymphoma, Large-Cell, Anaplastic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Phase: Phase 1/2 Status: Completed Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20032
20061
20072
20082
20094
20101
20113
20122
20151
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center3
M.D. Anderson Cancer Center2
Mayo Clinic2
Memorial Sloan Kettering Cancer Center2
University of Nebraska2
Acrotech Biopharma Inc.1
Ariad Pharmaceuticals1
Asan Medical Center1
Cancer Treatment Centers of America1
Children's Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic24
Immunoblastic Lymphadenopathy16
Hodgkin Disease15
Lymphoma, Large B-Cell, Diffuse13
Lymphoma, Mantle-Cell13
Lymphoma, B-Cell, Marginal Zone12
Lymphoma, Follicular12
Lymphoma, Non-Hodgkin12
Lymphoma, T-Cell, Cutaneous12
Mycosis Fungoides12

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.